Dr. Asnat Raziel

My articles

My articles

Shape-shifting capsule: how Epitomee creates fullness without drugs

The shape-shifting capsule: mechanics over chemistry

The shape-shifting capsule that expands inside the stomach is an Israeli development that tries to answer a simple question: can we create fullness without a drug? Hunger is not just a matter of willpower. It is a delicate physiological mechanism that operates along the axis between the stomach and the brain. For many people with a BMI (body mass index) in the 25-40 range, the existing solutions do not always fit. Lifestyle change alone is hard to sustain, while medication or surgery feels like too big a step.

The Epitomee capsule, made by Epitomee Medical of Caesarea, Israel, is a medical device, not a drug. Instead of intervening in the hormonal system, it offers an engineering solution based on the natural physiology of satiety.

The capsule is already reaching patients. According to a Globes report on its approval in Europe, sales in Israel began in December 2025 through the pharmaceutical company Rafa.

How the shape-shifting capsule works in the stomach

The capsule is made of pharmaceutical-grade absorbent polymers. Inside it is a flexible, perforated pouch, and inside the pouch are hydrogel particles, a gel that absorbs water. According to the RESET study paper, the outer capsule dissolves in the stomach. Next, water and stomach fluids enter the pouch, and the particles absorb them and expand. This creates a semi-rigid gel scaffold in the shape of a triangle.

Study participants swallowed one capsule with at least two full glasses of water (480 ml), 30 minutes before a main meal. They did this twice a day, preferably before lunch and before dinner. In fact, the water is the device’s fuel.

Why a triangle?

The triangular shape helps the structure withstand the stomach’s waves of contraction and stay there for several hours. According to the researchers, it probably activates stretch receptors in the stomach wall. These receptors, called mechanoreceptors, are sensors that respond to pressure and stretching. They send satiety signals to the brain through the gut-brain axis. The effect resembles eating a meal, but without the calories. I explained how the stomach and the brain talk to each other in my article on the physiology of satiety.

After a few hours the structure collapses and moves into the small intestine. There, once the pH rises above 6.5, the pouch breaks apart. Finally, the gel particles leave the body naturally. The amount of gel in each dose is very small, only 0.3 grams.

What the RESET trial showed

RESET was a randomized, double-blind, placebo-controlled trial conducted in the United States. It included 279 adults with a BMI of 27-40. All of them received intensive lifestyle support for 24 weeks. In the Epitomee group, weight fell by 6.6% on average, compared with 4.6% in the placebo group. In addition, 56% of capsule users lost at least 5% of their body weight. A loss of 10% or more was achieved by 27% of them, compared with only 11% in the placebo group.

The 8-week rule: an early sign of success

A follow-up analysis of the RESET study looked for an early sign of success. The researchers defined “early responders” as those who lost at least 2% of their body weight after eight weeks. Early responders to Epitomee reached an average loss of 9.3% after 24 weeks. By comparison, early responders to placebo reached 6.9%.

Moreover, an early responder to Epitomee was 4.1 times more likely to lose more than 5% of body weight. In other words, after just two months it is possible to tell whether the treatment is working. This is an important tool for both doctor and patient, because it saves time and frustration.

The shape-shifting capsule and metabolic markers

The metabolic analysis of RESET examined what happens beyond weight. Waist circumference, blood pressure and some blood sugar and lipid measures improved in both groups, with no significant difference between them. However, in participants with prediabetes, Epitomee lowered insulin levels and HOMA-IR, a measure of insulin resistance, compared with placebo. I have written before about the importance of treating prediabetes in time.

The most striking difference appeared in participants with metabolic syndrome. In this group, Epitomee users lost 8.3% of their body weight on average, compared with 5.2% on placebo. In addition, 40.7% of them lost 10% or more, compared with only 6.5% in the placebo group. Still, this was a small group of 27 patients on Epitomee and 31 on placebo.

Safety: no effect on the whole body

GLP-1 drugs sometimes cause digestive side effects. By contrast, the shape-shifting capsule is not absorbed into the bloodstream and does not act on hormones. In the RESET study, the rate of side effects was similar in both groups, and most were mild. Likewise, no serious device-related side effect was recorded.

The US Food and Drug Administration (FDA) granted the capsule marketing clearance in September 2024. The clearance is for adults with a BMI of 25-40, alongside diet and exercise. Even so, the researchers note that the capsule is not suitable for people who have had stomach surgery, or for those with reflux or a slow stomach (gastroparesis, partial paralysis of the stomach). For anyone looking for other options, I have gathered information on obesity treatment without surgery.

Infographic: shape-shifting capsule - how Epitomee works and what the RESET trial found

Looking ahead to smart weight management

In terms of strength, the shape-shifting capsule does not compete with the new drugs. Even the researchers themselves write that it leads to less weight loss than semaglutide. On the other hand, it offers a non-drug alternative with a favorable safety profile for people who need moderate weight loss. The ELECT extension study included people who had lost at least 3% of their weight in the original study. Among those who continued Epitomee for 48 weeks, the loss reached 11.2% on average. However, this was an open-label study with no control group.

Ultimately, this Israeli technology is a reminder that a solution can also be mechanical and simple. Even so, any treatment decision is best made with a doctor, as part of personalized obesity treatment. For related reading, see also my article on Epitomee treatment.

The information in this article is general and does not replace personal medical advice.

References

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study

Association of the Early Response to an Oral Shape-Shifting Superabsorbent Hydrogel Capsule With Weight Loss

Weight and cardiometabolic effects of a novel oral shape-shifting superabsorbent hydrogel capsule: Prespecified and exploratory analysis of the Epitomee capsule RESET study

The safety and efficacy of extended use of an oral shape-shifting superabsorbent hydrogel capsule for weight loss: The ELECT extension study

Epitomee Medical Announces FDA Clearance of its Capsule Weight Management Device

The studies were funded by Epitomee Medical, and some of the researchers are employees of or consultants to the company.

shape-shifting capsule - Epitomee, the capsule that changes shape

Dr. Asnat Raziel